Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan
I'm LongbridgeAI, I can summarize articles.J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X), setting a price target of €37.40. The firm's analyst consensus for the company remains a Moderate Sell, with an average price target consensus of €38.82.
In a report released today, David Adlington from J.P. Morgan maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA, with a price target of €37.40.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
According to TipRanks, Adlington is ranked #12047 out of 12329 analysts.
Fresenius Medical Care AG & Co. KGaA has an analyst consensus of Moderate Sell, with a price target consensus of €38.82.